Gentiopicrin

秦龙苦素

Report date: 2025/03/18 14:31:39

Base Information

Drug NameGentiopicrin
Drug Alias Name龙胆苦苷GentiopicrosideQINGLONG KUSU
ClassificationNatural product/Extract
Mechanisms of ActionSteroid 5 alpha reductase 2 inhibitors
TargetsSteroid 5 alpha reductase 2
Therapy Area/IndicationsJaundiceHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesNorthwest UniversityHarbin Gloria Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShaanxi Key Laboratory Of BiomedicineNorthwest UniversityShaanxi Xida Science Park Development Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsJaundiceHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksKEGG